CD19 and congenital rubella syndrome: To reduce ICANS and CRS and to diminish T-cell exhaustion, Ghorashian et al. (25) designed and investigated a low-affinity CD19.scFv (CAT CD19 CAR-T, Figure 1A), as discussed above.